Sangamo Therapeutics, Inc.

NASDAQ:SGMO

0.9 (USD) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996
Omzet 176.232111.299110.701118.192102.42884.45236.56719.38939.53945.8724.13321.65510.31920.80522.18716.1869.0987.8852.4841.3152.5794.3434.8853.4332.22.0381.1520.632
Kosten van de omzet 22.19212.1089.439180.647145.922114.86665.72865.61867.12856.74436.97931.70900000000000-5.232-0.7000
Brutowinst 154.0499.191101.262-62.455-43.494-30.414-29.161-46.229-27.589-10.874-12.846-10.05410.31920.80522.18716.1869.0987.8852.4841.3152.5794.3434.8858.6652.92.0381.1520.632
Brutowinstmarge 0.8740.8910.915-0.528-0.425-0.36-0.797-2.384-0.698-0.237-0.532-0.464111111111112.5241.318111
Onderzoek- en ontwikkelingskosten 230.457249.898230.819180.647145.922114.86665.72865.61867.19856.74436.97931.70932.09833.15428.98431.22925.55921.52711.41911.04610.18713.36315.51411.3474.34.2591.70.628
Algemene en administratieve kosten 61.16762.68263.21967.09761.68646.73627.226.3319.19715.67713.812.14414.04212.58612.60510.3328.317.0874.5124.2563.5944.1644.7500000
Verkoop- en marketingkosten -23.2920000000000000000000.66300000000
Verkoop-, algemene en administratieve kosten 37.87562.68263.21967.09761.68646.73627.226.3319.19715.67713.812.14414.04212.58612.60510.3328.317.0874.5124.9193.5944.1644.754.5691.81.2370.7970.322
Overige kosten 155.0130000000.8870.4310.3640.082-0.06614.0420010.3328.317.0874.8134.9194.16122.17413.0629.8012.5000
Bedrijfskosten 268.332312.58294.038247.744207.608161.60292.92891.94886.39572.42150.77943.85346.1445.7441.58941.56133.86928.61416.23215.96514.34835.53720.26421.1486.85.4962.4970.95
Bedrijfsresultaat -114.292-201.281-183.337-129.552-105.18-77.15-56.361-72.559-46.856-26.781-26.706-22.198-35.821-24.935-19.402-25.375-24.771-20.729-13.748-14.65-11.769-31.565-28.441-12.483-3.9-3.458-1.345-0.318
Bedrijfsresultaat ratio -0.649-1.808-1.656-1.096-1.027-0.914-1.541-3.742-1.185-0.584-1.107-1.025-3.471-1.199-0.874-1.568-2.723-2.629-5.535-11.141-4.563-7.268-5.822-3.636-1.773-1.697-1.168-0.503
Totaal overige inkomsten en kosten netto -148.6119.4325.3468.7759.7618.2611.7930.8870.431-0.23-0.06-0.0660.0710.0810.268-1.1580.0740.454-0.6960.2120.017-17.946-13.06200000
Inkomen voor belasting -262.903-191.849-177.991-120.777-95.419-68.889-54.568-71.672-46.425-26.417-26.624-22.264-35.75-24.854-18.587-24.302-21.48-17.864-13.293-13.818-10.433-29.764-25.24900000
Inkomen voor belasting ratio -1.492-1.724-1.608-1.022-0.932-0.816-1.492-3.697-1.174-0.576-1.103-1.028-3.464-1.195-0.838-1.501-2.361-2.266-5.351-10.508-4.045-6.853-5.16900000
Belastingkosten -5.0720.4290.3060.345-19.6018.261-1.498-0.014-5.722-0.683-0.591-0.66-0.646-0.676-0.815-1.073-1.42-2.179-0.455-0.832-1.336-1.439.87-3.417-0.13.2851.40.308
Nettowinst -257.831-192.278-178.297-121.122-75.818-68.334-54.568-71.658-40.703-26.417-26.624-22.264-35.75-24.854-18.587-24.302-21.48-17.864-13.293-13.818-10.433-29.764-25.249-9.066-3.8-3.285-1.4-0.308
Nettowinstmarge -1.463-1.728-1.611-1.025-0.74-0.809-1.492-3.696-1.029-0.576-1.103-1.028-3.464-1.195-0.838-1.501-2.361-2.266-5.351-10.508-4.045-6.853-5.169-2.641-1.727-1.612-1.215-0.487
WPA (Winst Per Aandeel) -1.48-1.25-1.23-0.9-0.68-0.7-0.7-1.02-0.58-0.39-0.48-0.42-0.71-0.55-0.44-0.6-0.58-0.55-0.51-0.55-0.42-1.22-1.09-0.52-0.63-0.56-0.26-0.06
Verwaterde WPA -1.48-1.25-1.23-0.9-0.68-0.7-0.7-1.02-0.58-0.39-0.48-0.42-0.71-0.55-0.44-0.6-0.58-0.55-0.51-0.55-0.42-1.22-1.09-0.52-0.63-0.56-0.26-0.06
EBITDA -92.1-201.281-183.337-129.552-105.18-77.15-56.361-72.559-46.856-26.321-26.586-22.198-35.821-24.935-19.098-23.694-24.845-21.183-12.564-13.382-9.615-10.7351.993-7.251-3.2-3.458-1.345-0.318
EBITDA ratio -0.523-1.808-1.656-1.096-1.027-0.914-1.541-3.742-1.185-0.574-1.102-1.025-3.471-1.199-0.861-1.464-2.731-2.686-5.058-10.176-3.728-2.4720.408-2.112-1.455-1.697-1.168-0.503